AF-10 Activators
The chemical class known as AF-10 Activators encompasses a diverse array of compounds designed to modulate the activity of AF-10, a protein encoded by the MLLT10 gene. AF-10 plays a pivotal role in cellular processes, particularly in the regulation of gene expression through chromatin modification. Activators of this class are histone deacetylase (HDAC) inhibitors. By inhibiting HDACs, these compounds alter histone acetylation patterns, potentially influencing AF-10-regulated gene expression. This marks the initiation of a cascade of molecular events that modulate chromatin structure and gene transcription, contributing to the intricate regulation of cellular processes governed by AF-10.
Beyond HDAC inhibition, AF-10 activators act as AF-10 activators through selective inhibition of histone methyltransferases. This modulation influences the methylation patterns on histones, impacting AF-10-regulated gene expression and further diversifying the regulatory mechanisms within this class. In addition, activators alter the binding of BET proteins to chromatin, presenting another mechanism for potential AF-10 activation. Lastly, activators of this class engage in various signaling pathways, such as NF-κB, LSD1, CDK5, CK2, and KDM6A, respectively, providing a rich landscape of mechanisms for potential AF-10 activation. The AF-10 Activators class thus offers a comprehensive toolbox for researchers to explore the intricate regulatory networks involved in AF-10 function, shedding light on the molecular underpinnings of gene expression control in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a potential AF-10 activator that can influence histone deacetylase (HDAC) activity. By inhibiting HDACs, trichostatin A may lead to increased acetylation of histones, potentially influencing AF-10 activity and gene expression. | ||||||
PFI 3 | 1819363-80-8 | sc-507340 | 10 mg | $300.00 | ||
PFI-3 is a chemical compound that may activate AF-10 through selective inhibition of the MLL (Mixed-Lineage Leukemia) family of histone methyltransferases. This inhibition may alter the methylation pattern on histones, impacting AF-10 function and downstream processes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a natural compound, can potentially activate AF-10 by modulating NF-κB signaling. Its role in inhibiting NF-κB activation may influence AF-10 expression and contribute to the regulation of cellular processes associated with AF-10. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid also known as vorinostat, is a potential activator of AF-10 through its inhibitory action on HDACs. Similar to trichostatin A, SAHA's HDAC inhibition may lead to altered histone acetylation patterns, influencing AF-10 activity and gene expression. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 is a chemical compound that may activate AF-10 by inhibiting the activity of the histone methyltransferase enzyme EZH2. Through the modulation of EZH2, UNC1999 could potentially impact the methylation patterns associated with AF-10-regulated genes. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
EPZ004777 is a potential AF-10 activator that selectively inhibits the histone methyltransferase DOT1L. By modulating DOT1L activity, EPZ004777 may influence the methylation patterns on histones, potentially impacting AF-10-regulated gene expression and cellular processes. | ||||||
Indirubin | 479-41-4 | sc-201531 sc-201531A | 5 mg 25 mg | $114.00 $525.00 | 4 | |
Indirubin is a potential AF-10 activator that may impact cyclin-dependent kinase 5 (CDK5) activity. By inhibiting CDK5, indirubin may lead to alterations in the phosphorylation status of proteins, potentially influencing AF-10-regulated gene expression and cellular processes. | ||||||
CGP 57380 | 522629-08-9 | sc-202993 | 5 mg | $172.00 | 6 | |
CGP 57380 is a potential AF-10 activator that may modulate casein kinase 2 (CK2) activity. By influencing CK2, CGP 57380 could potentially impact the phosphorylation status of proteins, contributing to the regulation of AF-10-regulated gene expression and cellular processes. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a potential AF-10 activator that functions as a proteasome inhibitor. By inhibiting the proteasome, MG-132 may lead to the accumulation of proteins involved in AF-10 signaling pathways, potentially impacting AF-10-regulated gene expression and cellular processes. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 is a potential AF-10 activator that may modulate the activity of the lysine-specific demethylase 6A (KDM6A). By influencing KDM6A, GSK-J4 could potentially impact the demethylation patterns on histones, contributing to the regulation of AF-10-regulated gene expression and cellular processes. | ||||||